Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05358171 · ClinicalTrials.gov registry record · NA
Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05358171 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 20 participants.
The verdict
NCT05358171, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Advancing age is associated with gut dysbiosis, low-grade chronic inflammation, progressive insulin resistance, and increased risk of type 2 diabetes (T2D). Prediabetes is present in 45-50% of middle-aged/older adults, and declines in glucose tolerance are evident in the third or fourth decade of life. Thus, there is an urgent need to identify new approaches for the prevention of type 2 diabetes among middle-aged adults. Observational research has linked intake of ultra-processed foods (UPF), which comprise \~60% of total energy intake in US adults, with increased risk of T2D. Ex vivo and animal research suggests that components of UPF alter gut microbiota composition and initiate a cascade of events leading to intestinal inflammation and impaired glycemic control. Whether mid-life adults (aged 45-65 yrs) are susceptible to the adverse impact of UPF consumption on glucose homeostasis is unknown. The overall objective of this study is to establish proof-of-concept for an impairment in glucose homeostasis following increases in UPF consumption in mid-life adults, in order to conduct a larger, more comprehensive and mechanistic trial in the future. In addition, changes in gut microbial composition and function, intestinal inflammation and permeability, serum endotoxin concentrations, and inflammatory cytokines as potential mechanisms by which UPF consumption influences glucose homeostasis will be investigated.
Interventions
- OTHER No UPF controlled diet
- OTHER HIgh UPF controlled diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05358171
The ClinicalTrials.gov registry entry for NCT05358171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No UPF controlled diet is the first listed.
NCT05358171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05358171 about?
NCT05358171 is a clinical study titled "Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis". Advancing age is associated with gut dysbiosis, low-grade chronic inflammation, progressive insulin resistance, and increased risk of type 2 diabetes (T2D). Prediabetes is present in 45-50% of middle-aged/older adults, and declines in glucose tolerance are evident in the third or fourth decade of li...
What is the current status of trial NCT05358171?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-03-15. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05358171?
The interventions under investigation include: No UPF controlled diet (OTHER), HIgh UPF controlled diet (OTHER).
Who is sponsoring clinical trial NCT05358171?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.